US Patent 7879353 Controlled or sustained-release formulation
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+510 characters)
Article
Patent abstract
A formulation comprising: a co-polyester comprising (a) the reaction product of a polycondensation polyester and (b) glycolide; wherein the polycondensation polyester comprises the reaction product of diglycolic acid and/or a derivative thereof and ethylene glycol, and the co-polyester comprises about 40% by weight of the polycondensation polyester based on the total weight of the co-polyester; and a drug selected from the group consisting of indomethacin, diclofenac sodium, and ketoprofen.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jenny Yuan0
Sasa Andjelic0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07879353 Controlled or sustained-release formulation US Patent 7879353 Controlled or sustained-release formulation
Infobox
Patent Number
078793530
Patent Number
78793530
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078793530
Date of Patent
February 1, 2011
0Patent Application Number
111109670
Date Filed
April 20, 2005
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07879353 Controlled or sustained-release formulation
Infobox
Is a
Patent jurisdiction
Patent number
07879353
Date of patent
February 1, 2011
Patent application number
11110967
Date Filed
April 20, 2005
Patent primary examiner
Find more entities like US Patent 7879353 Controlled or sustained-release formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.